메뉴 건너뛰기




Volumn 14, Issue 6, 2008, Pages 974-978

Achieving changes in practice from national audit: National audit of the organization of services for falls and bone health in older people

Author keywords

Achieving change; Action planning; Bone health; Falls; National audit; Older people

Indexed keywords

ARTICLE; BONE DISEASE; ELDERLY CARE; FALLING; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; MEDICAL AUDIT; MEDICAL PRACTICE; PRIORITY JOURNAL;

EID: 55649110928     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00915.x     Document Type: Article
Times cited : (5)

References (6)
  • 1
    • 55649120080 scopus 로고    scopus 로고
    • Falls
    • Department of Health (. In. pp. London: HMSO.
    • Department of Health (2001) Falls. In National Service Framework for Older People pp. 76 88. London : HMSO.
    • (2001) National Service Framework for Older People , pp. 76-88
  • 2
    • 55649117828 scopus 로고    scopus 로고
    • Royal College of Physicians, Clinical Effectiveness and Evaluation Unit. (.) National Audit of the Organisation of Services for Falls and Bone Health in Older People report. February 2006.
    • Royal College of Physicians, Clinical Effectiveness and Evaluation Unit. (2006) National Audit of the Organisation of Services for Falls and Bone Health in Older People report. February 2006.
    • (2006)
  • 3
    • 55649121236 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence. (.) Clinical Guideline (CG) 21, Falls: the assessment and prevention of falls in older people. November 2004.
    • National Institute for Health and Clinical Excellence. (2004) Clinical Guideline (CG) 21, Falls: the assessment and prevention of falls in older people. November 2004.
    • (2004)
  • 4
    • 55649104377 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence. (.) Technology appraisal (TA) 87, Bisphosphonates (alendronate, etidonate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in post menopausal women. January 2005.
    • National Institute for Health and Clinical Excellence. (2005) Technology appraisal (TA) 87, Bisphosphonates (alendronate, etidonate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in post menopausal women. January 2005.
    • (2005)
  • 6
    • 55649084223 scopus 로고    scopus 로고
    • NHS Institute for Innovation and Improvement. Available at: (last accessed 7 July 2006).
    • NHS Institute for Innovation and Improvement 2005) Delivering Quality and Value. Available at: http://www.institute.nhs.uk (last accessed 7 July 2006).
    • (2005)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.